Aceon Articles

New Zealand consults on amiloride, perindopril and trandolapril funding

11 March 2013

XOMA's perindopril and amlodipine FDC meets primary endpoint in Ph III blood pressure trial

23 November 2012

EU Commission focus now on Servier and others re-perindopril antitrust issues

31 July 2012

XOMA acquires US rights to perindopril franchise

18 January 2012

CV Thera narrows 1st-qtr 2007 loss to $55.1M

7 May 2007

CV Thera records 1st-qtr 2006 losses of $70.5M

8 May 2006

CV's fourth-quarter 2005 loss deepens 38%

13 March 2006

ASCOT redefines treatment of cardiovascular risk in hypertension

12 September 2005

Solvay/CV Thera's Aceon gets FDA decision delay

27 June 2005

Solvay files for new use of Aceon

20 December 2004

Daiichi Pharma

23 August 2004

Pretax profits down at Belgium's Solvay

18 February 2002

Solvay's Aceon reduces risk of stroke

18 June 2001

Belgium's Solvay places emphasis on growing pharmaceuticals further

12 February 2001

Profits and cash flow advances for Solvay

14 February 2000

Solvay looking for strong pharma growth

5 August 1999

Solvay Group agrees to acquire Unimed Pharmaceuticals for $123 million

14 June 1999

Solvay licenses Teveten from SB

13 May 1999

Solvay licenses perindopril in USA

6 May 1999

FDA YEAR-END APPROVALS FOR 1993

10 January 1994

Showing 1-20 of 20 articles

Go to beginningPrevious
  • 1
NextGo to end